Two-Punch combo aims to wipe out leukemia, offering hope for treatment breaks
Disease control
Terminated
This trial tested a two-drug combination (ibrutinib and venetoclax) for adults with chronic lymphocytic leukemia (CLL) that had returned or stopped responding to prior treatment. The goal was to see if using the drugs together could achieve a deep remission, potentially allowing …
Phase: PHASE2 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC